P. falciparum Life Cycle & Pathogenesis of Malaria Miller et al., Nature 2002  Molecular and genetic.

Slides:



Advertisements
Similar presentations
Gene Set Enrichment Analysis Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein.
Advertisements

Gene Set Enrichment Analysis Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein.
Gene Set Enrichment Analysis (GSEA)
Linking Genetic Profiles to Biological Outcome Paul Fogel Consultant, Paris S. Stanley Young National Institute of Statistical Sciences NISS, NMF Workshop.
Public data - available for projects 6 data sets: –Human Tissues –Leukemia –Spike-in –Arabidopsis mutants –Yeast Cell Cycle –Yeast Rosetta.
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
Microarrays Dr Peter Smooker,
Public data - available for projects 6 data sets: –Human Tissues –Leukemia –Spike-in –FARO compendium – Yeast Cell Cycle –Yeast Rosetta Find one yourself.
Copyright, ©, 2002, John Wiley & Sons, Inc.,Karp/CELL & MOLECULAR BIOLOGY 3E Transcriptional Control in Eukaryotes Background Information Microarrays.
Microarrays and Cancer Segal et al. CS 466 Saurabh Sinha.
Functional annotation and network reconstruction through cross-platform integration of microarray data X. J. Zhou et al
Epigenetics of Celiac Disease MEDICEL Malta 2011.
Comparative Genomic Hybridization (CGH). Outline Introduction to gene copy numbers and CGH technology DNA copy number alterations in breast cancer (Pollack.
Finding Transcription Modules from large gene-expression data sets Ned Wingreen – Molecular Biology Morten Kloster, Chao Tang – NEC Laboratories America.
Microarray Data Analysis Using R Studies in Tissue Databases Mark Reimers, NCI.
Inferring the nature of the gene network connectivity Dynamic modeling of gene expression data Neal S. Holter, Amos Maritan, Marek Cieplak, Nina V. Fedoroff,
DNA Microarrays Examining Gene Expression. Prof. GrossBiology 4 DNA MicroArrays DNA MicroArrays use hybridization technology to examine gene expression.
Review of important points from the NCBI lectures. –Example slides Review the two types of microarray platforms. –Spotted arrays –Affymetrix Specific examples.
Single Cell Informatics MI MII entry end. Motivation Some phenomena can only be seen when filmed at single cell level! (Here: excitability)
Epistasis Analysis Using Microarrays Chris Workman.
Comparative Expression Moran Yassour +=. Goal Build a multi-species gene-coexpression network Find functions of unknown genes Discover how the genes.
The Microbiome and Metagenomics
Analysis of microarray data
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
Development of new tools to study the cell biology and origins of phenotypic variation in the human pathogen Streptococcus pneumoniae: An overview of recently.
Unit 1: The Language of Science  communicate and apply scientific information extracted from various sources (3.B)  evaluate models according to their.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
From motif search to gene expression analysis
Compare and contrast prokaryotic and eukaryotic cells.[BIO.4A] October 2014Secondary Science - Biology.
William A. Craig Symposium ISAP Research Meeting PK/PD and Genomics David Andes University of Wisconsin.
A Systems Approach to Infectious Disease Research: Influenza Develop a molecular network model of the interaction between influenza virus and the innate.
MCB 317 Genetics and Genomics Topic 11 Genomics. Readings Genomics: Hartwell Chapter 10 of full textbook; chapter 6 of the abbreviated textbook.
Previously Cells need external signals to promote cell proliferation Cells have internal controls to limit # of divisions.
Lecture 7. Functional Genomics: Gene Expression Profiling using
Patterns in expression profiles point to mode of action in drug discovery © 2001,Pharmacia, Inc. - All Rights Reserved.
Data Mining the Yeast Genome Expression and Sequence Data Alvis Brazma European Bioinformatics Institute.
Idea: measure the amount of mRNA to see which genes are being expressed in (used by) the cell. Measuring protein might be more direct, but is currently.
Gene Expression and Epigenetic Regulation JESSICA LAINE AND ELIZABETH MARTIN.
Codon Bias and its Relationship to Gene Expression Presented through a virtual grant by the Virtual Student Union.
E14.5E16.5E18.5 Normalized mRNA level Get1 Nfix Smarcd3 A Supplementary Figure 1 (A) The microarray expression levels of bladder terminal differentiation.
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
Post-genomic Virology The impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions Steven Masson.
1 Genomics Advances in 1990 ’ s Gene –Expressed sequence tag (EST) –Sequence database Information –Public accessible –Browser-based, user-friendly bioinformatics.
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS) LECTURE 13 ANALYSIS OF THE TRANSCRIPTOME.
Microarray: An Introduction
CD47 modulates the phagocytic clearance and replication of Plasmodium yoelii malaria parasite Rajdeep Banerjee 1, Sanjay Khandelwal 2, Yukiko Kozakai 1,
NIDA Center Genomics Projects Kathie Walters October 2008.
A New Statistical Method for Analyzing Longitudinal Multifactor Expression Data and It ’ s Application to Time Course Burn Data Baiyu Zhou Department of.
Inferring Regulatory Networks from Gene Expression Data BMI/CS 776 Mark Craven April 2002.
Genome-wide Responses to Mitochondrial Dysfunction
Gene expression.
Skin Pharmacol Physiol 2017;30: DOI: /
Gene Hunting: Design and statistics
Presented by Meeyoung Park
Tai LT, Daran-Lapujade P, Walsh MC, Pronk JT, Daran JM
Unit III Information Essential to Life Processes
Biphasic metabolism of Protochlamydia during development in Acanthamoeba castellanii. Biphasic metabolism of Protochlamydia during development in Acanthamoeba.
The BRD4 bromodomain is critical for expression of SASP genes.
Characteristics of tissue‐specific co‐expression networks (CNs)‏
Genomic Profiling of Human Leishmania braziliensis Lesions Identifies Transcriptional Modules Associated with Cutaneous Immunopathology  Fernanda O. Novais,
Differential binding of H3K36me3 in G34-mutant KNS42 cells drives pediatric GBM expression signatures. Differential binding of H3K36me3 in G34-mutant KNS42.
Manoj T. Duraisingh, David Horn  Cell Host & Microbe 
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
RNA-seq of the clk-1(qm30) (± nuclear or WT clk-1) mutants.
RNA-Seq analysis of CYR1 cells in the adaptation to acid pH.
Distinct molecular and clinical correlates of H3F3A mutation subgroups
Interaction of platelet-decorated VWF strings with leukocytes and infected red blood cells in vitro. Interaction of platelet-decorated VWF strings with.
Transcriptome traits and clinical characteristics of TME phenotypes in the ACRG cohort. Transcriptome traits and clinical characteristics of TME phenotypes.
Presentation transcript:

P. falciparum Life Cycle & Pathogenesis of Malaria Miller et al., Nature  Molecular and genetic mechanisms underlying this diversity are poorly understood, but likely involve both host and pathogen biology Symptoms occur in the intraerythrocytic stage

Study Design  43 samples hybridized to custom P. falciparum (3D7) chip  28 samples also hybridized to HG_U133A chip  Diverse age range: 8.3 +/- 6.9 years  Illness severity: parasitemia 5.5% +/- 6.2%, hematocrit /- 6.8  43 samples hybridized to custom P. falciparum (3D7) chip  28 samples also hybridized to HG_U133A chip  Diverse age range: 8.3 +/- 6.9 years  Illness severity: parasitemia 5.5% +/- 6.2%, hematocrit /- 6.8 Screen 1900 Patients Hybridize 2 different chips Isolate human/parasite RNA directly from blood draw Velingara, Senegal

NMF Parasite Clusters & Patient Clinical Correlates Samples (n=43, NMF clustered) Genes (n=3900) 3 (n=18)2 (n=17) 1 (n=8) >3 Samples (n=43) NMF = Nonnegative Matrix Factorization

Gene Set Enrichment Analysis  The parasites look similar in each patient blood sample, early ring stage, however, GSEA identified gene sets differentially expressed between clusters  Major metabolic shift  Cluster 1: Starvation  Cluster 2: Glycolytic Metabolism  More like in vitro model  The parasites look similar in each patient blood sample, early ring stage, however, GSEA identified gene sets differentially expressed between clusters  Major metabolic shift  Cluster 1: Starvation  Cluster 2: Glycolytic Metabolism  More like in vitro model Subramanian et al., PNAS

195 Starvation (44, P=1.5X10 -7 ) General Tx mutants (23, P=2.8X10 -5 ) 469 Stress (278, P=4.6X ) 350 Glucose fermentation (168, P=2.3X ) P. falciparum array S. cerevisiae array  Large S. cerevisiae expression compendium projected onto the expression space defined by the 3 P. falciparum NMF clusters  Cluster 1 resembles a starvation response, while Cluster 3 resembles an environmental stress response, consistent with elevated markers of inflammation measured in patient sera  Large S. cerevisiae expression compendium projected onto the expression space defined by the 3 P. falciparum NMF clusters  Cluster 1 resembles a starvation response, while Cluster 3 resembles an environmental stress response, consistent with elevated markers of inflammation measured in patient sera Cross-species Projections

GSEA & NMF: Human Expression Profile  Clustering of human profiles did not match parasite clusters  Gene sets related to carbon sources were not enriched  e.g. Fatty acid, nitrogen, & glycolytic metabolism  Enrichment in many other gene sets (FDR≤0.05)  e.g. DNA replication, RNA transcription, and DNA repair  Clustering of human profiles did not match parasite clusters  Gene sets related to carbon sources were not enriched  e.g. Fatty acid, nitrogen, & glycolytic metabolism  Enrichment in many other gene sets (FDR≤0.05)  e.g. DNA replication, RNA transcription, and DNA repair 3 (n=4) k = 3; cophenetic coefficient = (n=16) 1 (n=8) These are not same three clusters seen in the parasite.

Methods  GSEA revealed gene sets with inflammatory response and oxidative phosphorylation gene signatures in human and gene sets related to cell cycle and virulence in parasite Clustered matrix of genes vs gene sets Created gene set from the union of 15 leading edges Identified “leading edge genes” that contributed to each enrichment (FWER≤0.05) GSEA using clinical correlate as phenotype continuous clinical variable (e.g. parasitemia, hematocrit, cytokine level) Human Clustered Gene SetsParasite Clustered Gene Sets Human Genes Parasite Genes blue: negatively correlated, red: positively correlated

Host-Pathogen Interaction  Can these metabolic shifts be explained by the host environment?  NMF on parasite profile using gene set reflects the previously identified clusters  Can these metabolic shifts be explained by the host environment?  NMF on parasite profile using gene set reflects the previously identified clusters k=3; cophenetic coefficient=0.999 k=2; cophenetic coefficient=0.988 k=4 cophenetic coefficient=0.992 NMF Clustering of Parasite Expression Profile Human Expression Profile of Clinically Correlated Genes P. falciparum Expression Profile of Clinically Correlated Genes 3 (n=18)2 (n=17) 1 (n=8) 3 (n=4)2 (n=16) 1 (n=8)

Conclusions & Future Work  Can we identify targets for updating previous models?  Previously unknown physiological diversity revealed in the in vivo biology of the malaria parasite  Update in vitro models by varying carbon sources and monitoring response to cytokines  Is there a biological story driving transcriptional changes?  Role of chromatin/global transcriptional mechanisms in mediating transcriptional shift  Host immune response possibly driving metabolic shifts in P. falciparum  R. Ordoñez was supported by the NIGMS Cell Decision Processes Grant #